Committed partner. Full portfolio. Backed by 5-year clinical data.4
Over 185,000 implants globally5
More than 40 clinical studies4
More than 950 patients studied4
Discovery. Diagnostics. Delivery.
Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.
Discovery. Diagnostics. Delivery.
Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.
Contact a sales rep to review Phasix™ Mesh clinical data
Contact Us
Over 143,000 implants globally4
More than 10 clinical studies5
More than 950 patients studied5
Low recurrence2,6-14
Low surgical site infection (SSI)2,6-14
Low seroma rates2,6-14
Video title here
Let's Connect
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Improved healing
from the start
Composed of biologically-derived material, poly-4-hydroxybutyrate (P4HB), Phasix™ Mesh provides critical strength during the initial healing phase with rapid tissue ingrowth and vascularization through its open-pore monofilament structure.1
Improved healing from the start
Composed of biologically-derived material, poly-4-hydroxybutyrate (P4HB), Phasix™ Mesh provides critical strength during the initial healing phase with rapid tissue ingrowth and vascularization through its
open-pore monofilament structure.1
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Store Tab
360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.
360° rotation knob is effectively sized
360° rotation knob is effectively sized
360° rotation knob is effectively sized
Improved healing from the start
Composed of biologically-derived material, poly-4-hydroxybutyrate (P4HB), Phasix™ Mesh provides critical strength during the initial healing phase with rapid tissue ingrowth and vascularization through its open-pore monofilament structure.1
Monomer form (4HB) is natural to the body1
Rapid tissue incorporation1
Organized and functional collagen at the repair site1
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Contact a sales rep to review Phasix™ Mesh clinical data
Hernia repair is always evolving. That’s why we’re proud to sponsor HerniaU, a dynamic online resource for hernia repair education events, including live surgeries, case studies, lectures, and comprehensive cutting-edge surgical training courses.
Predictable strength for the long run
Phasix™ Mesh gradually and predictably degrades within 12 to 18 months leaving behind a durable, functional repair with over 3x the strength of the native abdominal wall (NAW).1
Proven performance from a reliable partner
Low recurrence rates2,6-15
Low surgical site infection (SSI) rates2,6-15
Low seroma
rates2,6-14
Associated with improved quality of life16
Let's have a conversation
REFERENCES
1. Data on file. Preclinical results may not correlate to clinical performance. 2. Buell JF, et al. Initial experience with biologic polymer scaffold (Poly-4-hydroxybutyrate) in complex abdominal wall reconstruction. Ann Surg. 2017 Jul;266(1):185-188. 3. Results and experience may vary by patient. 4. Publications available upon request. 5. Data on file at BD. Phasix™ Mesh, Phasix™ ST Mesh, Phasix™ Plug, Phasix™ ST Mesh with Open Positioning System and Phasix™ ST Mesh with Echo 2™ Positioning System. As of February 28, 2021. 6. Levy AS, Bernstein JL, Premaratne ID, et al. Poly-4-hydroxybutyrate (Phasix™) mesh onlay in complex abdominal wall repair [published online ahead of print, 2020 May 8]. Surg Endosc. 2020;10.1007/s00464-020-07601-9. doi:10.1007/s00464-020-07601-9. 7. Roth JS, Anthone GJ, Selzer DJ, et al. Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-month follow-up. Surg Endosc. 2018;32(4):1929-1936. 8. Plymale MA, Davenport DL, Dugan A, Zachem A, Roth JS. Ventral hernia repair with poly-4-hydroxybutyrate mesh. Surg Endosc. 2018;32(4):1689-1694. 9. Wormer BA, Clavin NW, Lefaivre JF, et al. Reducing postoperative Abdominal bulge following deep inferior epigastric perforator flap breast reconstruction with onlay monofilament Poly-4-hydroxybutyrate biosynthetic mesh. J Reconstr Microsurg. 2017;33(1):8-18. 10. Messina NM, Rossi K, Wetherhold LM, et al. Optimizing donor site closure following bilateral breast reconstruction with abdominal-based free flaps. J Plast Reconstr Aesthet Surg. 2018;71(2):269-271. 11. Novitsky YW, et al. Prospective multicenter evaluation of ventral/incisional hernia repair with Poly-4-hydroxybutyrate mesh (Phasix™). Presented at AWR 2016. 12. Plymale M, et al. A comparison of ventral hernia repair outcomes between Phasix™ Mesh, permanent synthetic, and uncoated biologic mesh. Presented at SAGES 2017. 13. Abdelmoaty WF, Dunst CM, Filicori F, et al. Combination of surgical technique and bioresorbable mesh reinforcement of the crural repair leads to low early hernia recurrence rates with laparoscopic paraesophageal hernia repair. J Gastrointest Surg. 2020;24(7):1477-1481. 14. Panici Tonucci T, Asti E, Sironi A, Ferrari D, Bonavina L. Safety and efficacy of crura augmentation with Phasix™ ST Mesh for large hiatal hernia: 3-year single-center experience. J Laparoendosc Adv Surg Tech A. 2020;30(4):369-372. 15. Buell JF, et al. Long-Term Outcomes in Complex Abdominal Wall Reconstruction Repaired With Absorbable Biologic Polymer Scaffold (Poly-4-Hydroxybutyrate). Ann Surg. 2021 March; 1:e032 doi: 10.1097/AS9.0000000000000032. 16. Messa CA, Kozak G, Broach RB, Fischer JP. When the mesh goes away: An analysis of Poly-4-hydroxybutyrate mesh for complex hernia repair. Plast Reconstr Surg Glob Open. 2019;7(11):e2576. doi:10.1097/GOX.0000000000002576.
Phasix™ ST Mesh Indications Indicated for use in the reinforcement of soft tissue, where weakness exists, in procedures involving soft tissue repair, such as for the repair of hernias, including hiatal hernias.
Contraindications Because Phasix™ Mesh and Phasix™ ST Mesh are fully resorbable, they should not be used in repairs where permanent wound or organ support from the mesh is required.
Warnings Use of Phasix™ Mesh and Phasix™ ST Mesh in patients with known allergies to tetracycline hydrochloride or kanamycin sulfate should be avoided. The safety and effectiveness of these devices in pregnant or breastfeeding women, pediatric use, neural and cardiovascular tissue, and bridging repairs (Phasix™ ST Mesh only) has not been evaluated or established. If an infection develops, treat the infection aggressively. An unresolved infection may require removal of the mesh. Phasix™ Mesh must not be put in direct contact with bowel or viscera. Ensure proper orientation of Phasix™ ST Mesh; the coated side of the prosthesis should be oriented against the bowel or sensitive organs. There is a risk for adhesion formation or erosion if uncoated mesh side is placed against the bowel or viscera. For hiatal hernia repair, the use of Phasix™ ST Mesh circumferentially around the esophagus is not recommended. For hiatal hernia repair, the use of Phasix™ ST Mesh to bridge the hiatus is not recommended.
Adverse Reactions Possible complications may include, but are not limited to, seroma, adhesions, hematoma, pain, infection, inflammation, allergic reaction, hemorrhage, extrusion, erosion, mesh migration, fistula formation, wound dehiscence, and recurrence of the hernia or soft tissue defect. Possible complications in hiatal hernia repair (Phasix™ ST Mesh only) may include esophageal erosion and dysphagia related to crural fibrosis.
Please consult package insert for more detailed safety information and instructions for use. BD-28665
BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.